Approvals Update:

February 2012: Japanese PMDA approval received for our active pharmaceutical ingredients manufacturing facility.
    
December 2011: European GMP approval received for our finished formulations manufacturing facility.
October 2011: European GMP approval received for our active pharmaceutical ingredients manufacturing facility.
September 2011: US Food and Drug Administration's approval received for our active pharmaceutical ingredients manufacturing facility.